两名低补体血症性膜增生性肾小球肾炎患者血清中的C3肾炎因子和C4肾炎因子
C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
作者信息
Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M
机构信息
Second Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
出版信息
Clin Exp Immunol. 1989 Apr;76(1):82-5.
Abstract
Both C3 nephritic factor (C3NeF) and C4 nephritic factor (C4NeF) were found in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis type 1 (H-MPGN type 1). Both stabilizing activities were associated with the IgG fraction. The serum levels of C3 and C5 were quite low, whereas the levels of early components and control proteins were in the normal range.
摘要
在两名1型低补体血症性膜增生性肾小球肾炎（H-MPGN 1型）患者的血清中发现了C3肾炎因子（C3NeF）和C4肾炎因子（C4NeF）。两种稳定活性均与IgG组分相关。C3和C5的血清水平相当低，而早期补体成分和对照蛋白的水平在正常范围内。
相似文献
1
C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Clin Exp Immunol. 1989 Apr;76(1):82-5.
2
Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
Clin Exp Immunol. 1994 Feb;95(2):316-21. doi: 10.1111/j.1365-2249.1994.tb06530.x.
3
[Complement and nephritic activity in membranoproliferative glomerulonephritis].
Arch Fr Pediatr. 1979 Nov;36(9 Suppl):LXIV-LXXIV.
4
Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Clin Nephrol. 1982 Nov;18(5):240-6.
5
C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Clin Exp Immunol. 1986 Aug;65(2):450-7.
6
[Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
Nihon Jinzo Gakkai Shi. 1985 Oct;27(10):1345-52.
7
Detection of C3bBb-stabilizing activity (C3 nephritic factor) in the serum from patients with membranoproliferative glomerulonephritis.
J Immunol Methods. 1990 Jul 20;131(1):71-6. doi: 10.1016/0022-1759(90)90234-m.
8
9
[Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
Arch Fr Pediatr. 1977 Aug-Sep;34(7 Suppl):CXCVII-CCXII.
10
Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
Nephrol Dial Transplant. 1994;9(7):811-4.
引用本文的文献
1
Acquired drivers of C3 glomerulopathy.
Clin Kidney J. 2025 Jan 27;18(3):sfaf022. doi: 10.1093/ckj/sfaf022. eCollection 2025 Mar.
2
Challenges in diagnostic testing of nephritic factors.
Front Immunol. 2022 Nov 14;13:1036136. doi: 10.3389/fimmu.2022.1036136. eCollection 2022.
3
Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
Front Immunol. 2021 Aug 11;12:715704. doi: 10.3389/fimmu.2021.715704. eCollection 2021.
4
Complement C4, Infections, and Autoimmune Diseases.
Front Immunol. 2021 Jul 14;12:694928. doi: 10.3389/fimmu.2021.694928. eCollection 2021.
5
The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.
Clin Rev Allergy Immunol. 2020 Apr;58(2):229-251. doi: 10.1007/s12016-019-08774-5.
6
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.
Orphanet J Rare Dis. 2019 Nov 8;14(1):247. doi: 10.1186/s13023-019-1237-8.
7
Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.
Front Immunol. 2019 Apr 24;10:886. doi: 10.3389/fimmu.2019.00886. eCollection 2019.
8
Factor B and C4b2a Autoantibodies in C3 Glomerulopathy.
Front Immunol. 2019 Apr 4;10:668. doi: 10.3389/fimmu.2019.00668. eCollection 2019.
9
Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
Pediatr Nephrol. 2019 Aug;34(8):1311-1323. doi: 10.1007/s00467-018-3989-0. Epub 2018 Jun 9.
10
C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
Am J Kidney Dis. 2017 Dec;70(6):834-843. doi: 10.1053/j.ajkd.2017.07.004. Epub 2017 Aug 24.
本文引用的文献
1
Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Clin Nephrol. 1982 Nov;18(5):240-6.
2
Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein.
J Immunol. 1980 Nov;125(5):2051-4.
3
4
Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme.
J Clin Invest. 1980 Jun;65(6):1249-56. doi: 10.1172/jci109787.
5
A new method for the preparation of EAC14 cell with human or guinea-pig serum.
J Immunol Methods. 1974 Aug;5(3):307-17. doi: 10.1016/0022-1759(74)90117-3.
6
Complement and the kidney.
Proc R Soc Med. 1972 Dec;65(12):1095-8. doi: 10.1177/003591577206501221.
7
Serum C'3 lytic system in patients with glomerulonephritis.
Science. 1969 Apr 25;164(3878):436-7. doi: 10.1126/science.164.3878.436.
8
C4 nephritic factor in a patient with chronic glomerulonephritis.
J Clin Lab Immunol. 1987 Feb;22(2):65-70.
9
Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
J Immunol. 1985 Jul;135(1):440-4.
10
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
J Immunol. 1976 Jan;116(1):1-7.
Zotero 插件